Editorial Commentary: Early High-Dose Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Elevated Vancomycin Minimum Inhibitory Concentrations: Ready for Prime Time?

By Weston Adam   Boucher Helen W.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1570-1572

Oxford University Press

Access to resources Recommend Favorite

Registered and Investigational Drugs for the Treatment of Methicillin-Resistant Staphylococcus aureus Infection

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 10-33

Bentham Science Publishers

Access to resources Recommend Favorite

Methicillin-Resistant Staphylococcus aureus: Treatment with Cultures of Non Drug-Resistant Staphylococcus epidermidis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 10, Iss. 2, 2015-08 ,pp. : 124-127

Bentham Science Publishers

Access to resources Recommend Favorite

Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study

By Murray Kyle P.   Zhao Jing J.   Davis Susan L.   Kullar Ravina   Kaye Keith S.   Lephart Paul   Rybak Michael J.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1562-1569

Oxford University Press

Access to resources Recommend Favorite

Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus : comparison with vancomycin, linezolid and daptomycin

By Mélard Aurélie   Garcia Laetitia G.   Das Debaditya   Rozenberg Raoul   Tulkens Paul M.   Van Bambeke Françoise   Lemaire Sandrine  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 648-658

Oxford University Press

Access to resources Recommend Favorite